Latest News for: argen

Edit

argenx Announces Annual General Meeting of Shareholders on May 27, 2025 (arGEN-X SE)

Public Technologies 11 Apr 2025
). April 11, 2025, 10.01 PM CET. Amsterdam, the Netherlands - argenx SE (Euronext & Nasdaq ... Agenda ... About argenx ... Media.. Ben Petok ... arGEN-X SE published this content on April 11, 2025, and is solely responsible for the information contained herein.
Edit

argenx Announces FDA Approval of VYVGART Hytrulo Prefilled Syringe for Self-Injection in Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy (Form 6-K) (arGEN-X SE)

Public Technologies 11 Apr 2025
) ... · Approval reflects commitment to innovating the patient experience with individualized, safe and effective therapies ... · Infection ... arGEN-X SE published this content on April 11, 2025, and is solely responsible for the information contained herein.
Edit

argenx SE, - argenx Highlights VYVGART Data at AAN 2025 Setting New Standard in Sustained Efficacy and Improved Quality of Life Measures for Patients Living with gMG and CIDP (arGEN-X SE)

Public Technologies 08 Apr 2025
) argenx SE argenx SE ... Previous result ... Disclaimer. arGEN-X SE published this content on April 08, 2025, and is solely responsible for the information contained herein.
Edit

argenx Highlights VYVGART Data at AAN 2025 Setting New Standard in Sustained Efficacy and Improved Quality of Life Measures for Patients Living with gMG and CIDP (Form 6-K) (arGEN-X SE)

Public Technologies 08 Apr 2025
). argenx Highlights VYVGART Data at AAN 2025 Setting New Standard in Sustained Efficacy and ... April 8, 2025, 7.00 AM CET ... (Symposium ... 3 ... 4 ... arGEN-X SE published this content on April 08, 2025, and is solely responsible for the information contained herein.
Edit

argenx Highlights VYVGART Data at AAN 2025 Setting New Standard in Sustained Efficacy and Improved Quality of Life Measures for Patients Living with gMG and CIDP (arGEN-X SE)

Public Technologies 08 Apr 2025
April 8, 2025, 7.00 AM CET. Amsterdam, the Netherlands - argenx SE (Euronext & Nasdaq ... efgartigimod alfa-fcab and SC or Hytrulo ... arGEN-X SE published this content on April 08, 2025, and is solely responsible for the information contained herein.
  • 1
×